Design of a registry to characterize “real-world” outcomes of percutaneous coronary revascularization in the drug-eluting stent era
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 150 (5), 887-892
- https://doi.org/10.1016/j.ahj.2005.03.030
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Meta-analysis comparing drug-eluting stents with bare metal stentsThe American Journal of Cardiology, 2005
- Coronary syndromes following aspirin withdrawalJournal of the American College of Cardiology, 2005
- Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresJournal of the American College of Cardiology, 2004
- Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous proceduresThe Annals of Thoracic Surgery, 2004
- Analysis of 1-Year Clinical Outcomes in the SIRIUS TrialCirculation, 2004
- A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with ClopidogrelNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Efficacy and safety of minimal dose (≤1,000 Units) unfractionated heparin with abciximab in percutaneous coronary interventionThe American Journal of Cardiology, 2003
- Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placementHeart, 2001
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983